Mohawk Industries (MHK) Proxy filing summary
Event summary combining transcript, slides, and related documents.
Proxy filing summary
3 Apr, 2026Executive summary
Annual Meeting scheduled for May 21, 2026, to elect three Class I directors, ratify KPMG LLP as auditor, hold a say-on-pay vote, approve a new 2026 Incentive Plan, and consider a shareholder proposal on majority voting.
2025 sales reached $10.8B with adjusted EBITDA of $1.3B and free cash flow of $616M; net sales decreased 0.5% from 2024, with continued market challenges impacting volumes and profitability.
The company advanced operational improvements, product innovation, and sustainability initiatives to position for future growth.
Voting matters and shareholder proposals
Proposals include election of three Class I directors, ratification of KPMG LLP, advisory approval of executive compensation, approval of the 2026 Incentive Plan, and a shareholder proposal to adopt a majority vote standard.
The Board recommends voting FOR all management proposals and AGAINST the shareholder proposal on majority voting.
Board of directors and corporate governance
Board consists of nine directors in three staggered classes, with a classified board structure to promote stability and long-term focus.
Two-thirds of directors are independent; a Lead Independent Director role enhances oversight.
Board committees include Audit, Compensation, and Nominating & Corporate Governance, all composed of independent directors.
Annual board and committee self-evaluations and a robust nomination process are in place.
Stockholder engagement is emphasized, with regular outreach and communication channels.
Latest events from Mohawk Industries
- Q4 2025 net sales rose 2.4% to $2.7B; 2026 outlook expects improved sales and earnings.MHK
Q4 202527 Feb 2026 - Q2 adjusted EPS up 9% as cost actions and cash flow offset weak sales and market pressures.MHK
Q2 20242 Feb 2026 - Q3 2024 adjusted EPS up 7% to $2.90; 2025 recovery expected as rates decline.MHK
Q3 202418 Jan 2026 - Q1 2025 sales fell 5.7% to $2.53B; adjusted EPS $1.52; tariffs add $50M in costs.MHK
Q1 202525 Dec 2025 - Adjusted EPS steady at $1.95 as cost actions offset weak demand; $285M savings targeted.MHK
Q4 20249 Dec 2025 - Proxy covers director elections, auditor ratification, executive pay, and ESG priorities.MHK
Proxy Filing1 Dec 2025 - Q3 2025 sales up 1.4% to $2.8B, with $110M in savings and ongoing cost actions amid soft demand.MHK
Q3 202524 Oct 2025 - Flat Q2 2025 sales, margin pressure, and a $500M buyback amid ongoing cost and tariff risks.MHK
Q2 202525 Jul 2025